Ram Kapoor reveals secret behind his 50kg weight loss
Actor Ram Kapoor opens up about his 55kg weight loss journey, battling type-2 diabetes, and his mindset shift. Discover his inspiring health transformation story.
Actor Ram Kapoor opens up about his 55kg weight loss journey, battling type-2 diabetes, and his mindset shift. Discover his inspiring health transformation story.
Psyllium husk, dubbed 'Desi Ozempic,' is trending as a natural appetite suppressant. Discover how this common fiber compares to prescription drugs and its role in weight management.
Karnataka Health Minister Dinesh Gundu Rao announces state will appeal HC order quashing closure of Jan Aushadi Kendras in govt hospitals. Read the full story.
Shark Tank India's Anupam Mittal comments on Ozempic's India launch, its ₹8,800/month price, and the 2026 patent expiry that could 5x the market. Read his take on fitness shortcuts vs. discipline.
Delhi High Court rejects Novo Nordisk's patent plea on semaglutide (Ozempic/Wegovy), preventing 'evergreening'. A win for affordable generics in India, but raises concerns over non-clinical misuse of weight-loss drugs. Read more.
WHO releases first-ever global guidelines for GLP-1 medicines to treat obesity, a chronic disease. Learn about the key recommendations and new mental health warnings from Australia.
Australia's TGA issues a safety warning for GLP-1 drugs like Ozempic, linking them to suicidal thoughts and depression. Over 500,000 users affected. Learn the risks and what patients must do.
The 'Ozempets' trend of using human weight-loss drugs like Ozempic on pets is growing. Experts warn of severe risks as these drugs are not approved for animals. Learn safe alternatives.
Delhi High Court permits Dr Reddy's to export generic semaglutide, a major win for Indian drugmakers eyeing the booming anti-obesity market. Read the full analysis.
Eli Lilly's daily pill orforglipron shows 12% weight loss in trials, potentially revolutionizing obesity treatment. Could this be the end of injections?
Novo Nordisk and Eli Lilly develop daily oral weight loss pills with 10-16% average weight loss in trials. Pending FDA approval, these could replace injections.
Discover 5 winter foods that naturally mimic Ozempic effects for weight loss and blood sugar control. Scientific study reveals natural alternatives to weight loss drugs with fewer side effects.
Struggling with Thanksgiving feast on Ozempic? Dietitian Kylie Bensley reveals how to enjoy holiday foods without digestive discomfort. Learn smart eating strategies.
US government announces major Medicare price reductions for 15 prescription drugs including Ozempic, Wegovy and cancer treatments. Savings expected from 2027. Read more.
Americans on GLP-1 medications are skipping doses and adjusting menus for Thanksgiving feasts. Discover how these powerful drugs are reshaping holiday traditions and eating habits.
Lizzo reveals mental health struggles behind her transformation while warning about Ozempic boom's impact on body positivity movement and representation.
Michelle Obama faces Ozempic rumors after revealing slimmer frame in Annie Leibovitz photoshoot. Social media erupts with speculation despite no evidence. Read the full story.
Michelle Obama's latest photoshoot with Annie Leibovitz ignited online debate about her slimmer appearance, with many speculating about weight loss drugs. Discover the full story.
Secret Lives of Mormon Wives star Whitney Leavitt lost 20 pounds using Ozempic but stopped due to severe side effects including nausea and diarrhea. Read her full story.
New research reveals whey protein shakes before meals can suppress appetite and regulate blood sugar like Ozempic. Discover how this natural alternative works for weight loss and diabetes management.
Novo Nordisk reduces Wegovy's price by 37% in India as it faces patent loss and competition from Eli Lilly's Mounjaro and upcoming generic versions. Discover the new costs.
Former President Donald Trump reveals groundbreaking agreement with pharmaceutical giants to dramatically reduce costs of popular weight loss medications, promising relief for millions struggling with obesity.
In a major breakthrough for weight management, the White House has secured a deal that significantly reduces prices of popular drugs Ozempic and Wegovy, making effective weight loss treatment more accessible across India.
Indian pharmaceutical companies are reporting exceptional earnings driven by US generic drug sales, leading to major fundraising initiatives for expansion into medtech and wellness sectors.
Danish pharmaceutical giant Novo Nordisk faces turbulent times as Q3 profits drop 27% despite Ozempic's success. The company announces massive restructuring with 9,000 job cuts worldwide. Get the inside story on what's happening behind the scenes.
Former US President Donald Trump is negotiating with Novo Nordisk to offer weight-loss drugs at just $149. Discover how this could revolutionize affordable healthcare and impact India's growing obesity crisis.
Explore how revolutionary weight-loss medications like Ozempic are transforming lives while raising crucial questions about accessibility, side effects, and long-term sustainability in the Indian context.
Discover how GLP-1 receptor agonists are revolutionizing diabetes and obesity treatment. Learn the mechanism behind popular drugs like Ozempic, Mounjaro, and other game-changing medications.
Discover how revolutionary GLP-1 medications including Ozempic, Wegovy, and Mounjaro are transforming America's battle against obesity, offering new hope for sustainable weight loss.
Groundbreaking research shows popular weight-loss drug semaglutide significantly reduces heart disease risk, offering dual benefits for patients struggling with obesity and cardiovascular health.